Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
linezolid, Quantity: 600 mg
Amneal Pharma Australia Pty Ltd
Linezolid
Tablet
Excipient Ingredients: povidone; croscarmellose sodium; purified talc; silicon dioxide; microcrystalline cellulose; diethyl phthalate; magnesium stearate; ethylcellulose; hypromellose; titanium dioxide
Oral
10, 30
(S4) Prescription Only Medicine
Linezolid is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,Linezolid is active against Gram-positive bacteria only. It has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.
Visual Identification: White to off white, oval shaped, film coated tablets, debossed with AI006 on one side and plain on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2016-06-01